Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
NFL
Baseball
2024 US Election
Donald Trump
Joe Biden
Tornado
US Politics
US Economy
US Social Issues
Republican Party
US Crime
David Pecker
Get access to our best features
Get Started
Published 1 month ago

Philadelphia District Attorney sues pharmaceutical companies over insulin prices

Summary by Ground News
Philadelphia District Attorney Larry Krasner filed a lawsuit against nearly 20 pharmaceutical companies and pharmacy benefit managers. The suit alleges that the companies targeted in the action are in violation of the Pennsylvania Unfair Trade Practices and Consumer Protection Law. A 2022 study found that more than 1.3 million Americans with diabetes did not take their full described daily doses of insulin due to the cost.

0 Articles

All
Left
Center
Right
abc 6 Philadelphiaabc 6 Philadelphia

Philadelphia District Attorney sues pharmaceutical companies over insulin prices

District Attorney Larry Krasner announced a lawsuit against big pharmaceutical companies, alleging they are keeping insulin prices artificially high.

1 month ago·Philadelphia, United States
Read Full Article
InquirerInquirer

Philadelphia DA Larry Krasner sues insulin makers, pharmacy benefit managers, over high prices

Eli Lily and CVS are among the companies named in the lawsuit.

1 month ago·Philadelphia, United States
Read Full Article
NBC PhiladelphiaNBC Philadelphia

Philly DA Larry Krasner sues nearly 20 pharmaceutical companies over 'artificially high' insulin prices

Philadelphia District Attorney Larry Krasner filed a lawsuit against nearly 20 pharmaceutical companies and pharmacy benefit managers over, what his office called, the "artificially high" cost of insulin.

1 month ago·Philadelphia, United States
Read Full Article
The Philadelphia TribuneThe Philadelphia Tribune

Philadelphia DA sues companies for inflating insulin prices

The district attorney’s office announced it will sue nearly 20 pharmaceutical companies, including CVS, and related benefits managers, over what the office alleges are grossly-inflated insulin prices affecting people with diabetes.

1 month ago·Philadelphia, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

CVSCVS
Eli LillyEli Lilly
Philadelphia, PennsylvaniaPhiladelphia, Pennsylvania
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal